Danaher boosted the upper end of its full-year earnings guidance, following a first-quarter beat fueled by double-digit ...
On February 16, Franklin Equity said the biotechnology industry has entered 2026 on a firmer footing following an extended ...
StockStory.org on MSN
Biotechnology stocks Q3 results: Benchmarking Natera (NASDAQ:NTRA)
Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same ...
1.1a Congress must establish a National Biotechnology Coordination Office (NBCO) within the Executive Office of the President with a director, appointed by the President, who would coordinate ...
Do you want to be at the forefront of the rapidly growing biotechnology field? Do you want to develop products derived from living organisms and biomolecules? Do you have a passion for biochemistry, ...
Alabama A&M University students made a strong showing at a statewide biotechnology symposium, bringing home top honors at the ...
At the center of AV Laboratories’ innovation is its patented AVL SOM3® complex, a scientifically engineered formulation ...
Columbia Daily Tribune on MSN
Missouri S&T plans new biochemistry bachelor’s degree
Missouri S&T’s proposed biochemistry program would combine lab research, data analysis and life sciences to meet growing ...
Vir Biotechnology, Inc. (NASDAQ:VIR) is one of the must-buy small cap stocks to buy. On April 13, Vir Biotechnology, Inc.
The longevity biotechnology industry is rapidly evolving with the amount of academic funding and venture investment increasing at the exponential pace. Over thirty longevity startups and approximately ...
Biotechnology advances offer immense public health and consumer potential, but come with serious risks. A recent workshop held by the Council on Foreign Relations brought experts together to discuss ...
EU Biotech Act I simplifies trials, boosts biomanufacturing, and aims for €10B investment to strengthen Europe's health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results